Marking a Quarter Century of Science, Innovation, and Global Trust
SFI Health™ proudly celebrates the 25th anniversary of Equazen®, a globally recognised, science-backed food supplement brand dedicated to supporting cognitive function and brain health. Since its market debut in 2000, Equazen® has remained at the forefront of innovation, consistently upholding pharma-quality standards to deliver trusted solutions for families, healthcare professionals, and business partners worldwide.
A Legacy Rooted in Science
The journey of Equazen® began in 1999 in the UK, when Professor Horrobin conducted pioneering research on the relationship between essential fatty acids and paediatric cognitive function. His findings led to the development of the first Equazen® formula, initially launched as Eye Q. By introducing a unique blend of essential fatty acids, the product laid the foundation for Equazen®’s continued evolution and success.
Since then, Equazen® has remained committed to combining naturally sourced ingredients with rigorous scientific validation. The formula is designed to provide optimal support for cognitive function, focus, and learning abilities, making it a trusted choice among parents and healthcare professionals alike.
Science-Driven Innovation for Cognitive Health
Equazen® has been the subject of clinical research for over two decades, with its first published clinical evidence appearing in 2005. These studies have demonstrated the supplement’s effectiveness in enhancing learning capabilities, concentration, and overall cognitive well-being.
To ensure accessibility for diverse needs, Equazen® has expanded its range to include various pharmaceutical formats suitable for infants, children, teenagers, and adults. One of the latest innovations, Equazen® Jelly, delivers the brand’s signature blend of essential fatty acids in a delicious, fruity-flavoured format. Designed to appeal to picky eaters, this patent-protected formulation ensures easier ingestion and improved absorption.
Global Recognition and Healthcare Endorsements
Equazen® has earned the trust of healthcare professionals, researchers, and consumers worldwide. Its reputation is built on scientific integrity, clinically proven benefits, and a commitment to quality.
✔ Matthew Brabazon, GM of SFI Health™ EMEA, stated: “Watching Equazen® grow and evolve over the past 25 years has been truly remarkable. As we look to the future, we are excited to continue expanding our portfolio and bringing innovative cognitive health solutions to people worldwide.”
✔ Zbyszek Czop, Managing Director of Qpharma Sp. z o.o., distributor of Equazen® in Poland, added: “Gaining the confidence of medical professionals through robust clinical trials is incredibly rewarding. More doctors now recognise the positive impact of Equazen® on children’s cognitive health, particularly for those with attention and behavioural challenges.”
✔ Kirsten Jorsal, Founder of Novasel EU, distributor of Equazen® in Denmark, highlighted: “Equazen® is unique due to its precise balance of essential fatty acids, with a higher EPA-to-DHA ratio than standard fish oil supplements. This, combined with its strong scientific backing, sets it apart in the market.”
Commitment to Future Growth
With its deep understanding of consumer needs and scientific advancements, Equazen® is available in over 30 countries across five continents. As the demand for natural, research-backed cognitive support continues to rise, SFI Health™ remains dedicated to expanding the brand’s global footprint.
By integrating science, innovation, and premium-quality formulations, Equazen® continues to shape the future of cognitive health, ensuring individuals of all ages can benefit from its proven efficacy.